Western Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Western Wealth Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$301K	Hold	20,317	–	–	0.01%	799
2025 Q4	$324K	Hold	20,317	–	–	0.01%	636
2025 Q3	$225K	Buy	20,317 +317	+2%	+$3.46K	0.01%	698
2025 Q2	$169K	Hold	20,000	–	–	0.01%	711
2025 Q1	$161K	Hold	20,000	–	–	0.01%	662
2024 Q4	$180K	Hold	20,000	–	–	0.01%	647
2024 Q3	$147K	Buy	+20,000	New	+$124K	0.01%	727
2022 Q3	–	Sell	-26,650	Closed	-$269K	–	810
2022 Q2	$269K	Sell	26,650 -600	-2%	-$6.71K	0.02%	644
2022 Q1	$338K	Buy	+27,250	New	+$421K	0.02%	635

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Western Wealth Management's AUPH Position: Q1 2026 in Review

Western Wealth Management held its Aurinia Pharmaceuticals (AUPH) position steady in Q1 2026 at 20,317 shares worth $301K. The position accounts for 0.01% of the portfolio, ranked #799.

Western Wealth Management first reported a position in AUPH in Q1 2022 and has held it in 9 quarters since. The position peaked at $338K in Q1 2022. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

Western Wealth Management held 20,317 shares of Aurinia Pharmaceuticals worth $301K as of Q1 2026.
Western Wealth Management left its Aurinia Pharmaceuticals share count unchanged in Q1 2026.
Aurinia Pharmaceuticals made up 0.01% of Western Wealth Management's portfolio in Q1 2026, its #799 holding.
Western Wealth Management first reported a position in Aurinia Pharmaceuticals in Q1 2022 and has held it in 9 quarters since.
Western Wealth Management's Aurinia Pharmaceuticals position peaked at $338K in Q1 2022.
259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Western Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.